Doctor profile · Federal record

Dr. Mahnaz Momeni, MD

Rheumatology Physician (CMS: Rheumatology) · Vienna, VA

  • NPI 1306924741
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 32 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8130 Boone Blvd, Suite#340
Vienna, VA 221822666
(703) 734-2222
fax (703) 734-2223

Credentials & registration

NPPES · NUCC
NPI registered
November 2006 — 20 yrs on file
Profile last updated
March 5, 2015
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Virginia #0101233154
Medicaid
DC #036856100

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1306924741. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
133,761
Distinct HCPCS
10
Medicare allowed
$963,359
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 125,600 35 $5
J0897 Injection, denosumab, 1 mg 6,300 83 $23
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 626 35 $87
99214 Established patient office or other outpatient visit, 30-39 minutes 610 330 $138
99213 Established patient office or other outpatient visit, 20-29 minutes 151 122 $99
96372 Injection of drug or substance under skin or into muscle 113 88 $16
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance 86 40 $118
99204 New patient office or other outpatient visit, 45-59 minutes 80 80 $187
96413 Administration of chemotherapy into vein, 1 hour or less 77 16 $148
J1040 Injection, methylprednisolone acetate, 80 mg 45 32 $10

In context: peer comparison

Among 1 peers in Vienna Rheumatology Physician, average services per provider: 10,289. This provider delivers 13× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,370
Transactions
133
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 23 $766.08
Abbvie INC. 17 $446.11
Novartis Pharmaceuticals Corporation 16 $403.81
Ucb, INC. 26 $388.56
Mallinckrodt Hospital Products INC. 9 $320.29
Amgen INC. 11 $254.23
Fresenius Kabi USA, LLC 5 $129.54
GlaxoSmithKline, LLC. 6 $118.34
Aurinia Pharma U.S., INC. 4 $76.90
Alexion Pharmaceuticals, INC. 3 $74.32
Pfizer INC. 3 $68.62
Ani Pharmaceuticals, INC. 3 $58.75
Lilly USA, LLC 2 $49.64
Kiniksa Pharmaceuticals International, Plc 3 $46.47
Sandoz INC. 2 $40.86

By nature of payment

Food and Beverage
$3,260
Education
$110

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
786
Patients
225
Total drug cost
$905,185
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 166 54 $7,097
Prednisone Generic 106 44 $1,466
Hydroxychloroquine Sulfate Generic 70 22 $6,703
Alendronate Sodium Generic 67 20 $1,154
Leucovorin Calcium Generic 66 23 $2,867
Enbrel Sureclick (Etanercept) Brand 53 0 $433,526
Celecoxib Generic 43 24 $1,602
Humira(Cf) Pen (Adalimumab) Brand 37 0 $271,852
Gabapentin Generic 31 15 $389
Colchicine Generic 26 11 $3,322

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mahnaz Momeni's medical specialty?
Dr. Mahnaz Momeni practices Rheumatology Physician in Vienna, VA.
Where does Dr. Mahnaz Momeni practice?
Dr. Mahnaz Momeni practices at 8130 Boone Blvd, Vienna, VA 221822666. Office phone: 7037342222.
What is Dr. Mahnaz Momeni's NPI?
Dr. Mahnaz Momeni's National Provider Identifier (NPI) is 1306924741, issued by NPPES.
Does Dr. Mahnaz Momeni accept Medicare assignment?
Yes. Dr. Mahnaz Momeni accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mahnaz Momeni commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS 96401). Source: CMS Medicare Physician & Other Practitioners file.